|
NUDT22 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.342500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.935800E-02 |
| Normal-vs-Stage2 |
2.379100E-04 |
| Normal-vs-Stage3 |
1.102780E-01 |
| Normal-vs-Stage4 |
4.380200E-01 |
| Stage1-vs-Stage2 |
6.156500E-03 |
| Stage1-vs-Stage3 |
8.542200E-01 |
| Stage1-vs-Stage4 |
1.712820E-01 |
| Stage2-vs-Stage3 |
6.898600E-03 |
| Stage2-vs-Stage4 |
1.077390E-03 |
| Stage3-vs-Stage4 |
3.592400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.952400E-02 |
| Normal-vs-AfricanAmerican |
6.568200E-01 |
| Normal-vs-Asian |
4.975400E-01 |
| Caucasian-vs-AfricanAmerican |
3.115200E-01 |
| Caucasian-vs-Asian |
9.184400E-02 |
| AfricanAmerican-vs-Asian |
9.390000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.561550E-02 |
| Normal-vs-Female |
4.297600E-02 |
| Male-vs-Female |
4.161200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.327500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.224100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.061970E-02 |
| Normal-vs-Age(81-100Yrs) |
9.730000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.664400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.077600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.070400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.292600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.322200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.817200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.639000E-01 |
| Classical-VS-Follicular |
2.1787999999745E-06 |
| Classical-VS-Other |
9.337400E-01 |
| Classical-VS-Normal |
2.513600E-01 |
| Tall-VS-Follicular |
1.397180E-03 |
| Tall-VS-Other |
6.797600E-01 |
| Tall-VS-Normal |
9.432600E-01 |
| Follicular-VS-Other |
1.776420E-01 |
| Follicular-VS-Normal |
1.51057999999704E-05 |
| Other-VS-Normal |
6.046800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.968600E-04 |
| Normal-vs-N1 |
3.221200E-01 |
| N0-vs-N1 |
6.977600E-02 |
|
|
